article

1. Reduced circulating progenitor cells in older adults with major depression: Evidence of accelerated biological aging..  Brain, behavior, & immunity - health.  -. 2026
2. Physical activity, health symptoms, and falls in older adults with different cognition levels: evidence from the Health and Retirement Study..  BMC geriatrics.  26. 2026
3. Moderators of treatment response in late-life depression..  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.  2026
4. Plasma but not salivary p-Tau181 reflects Alzheimer's disease in a Latin American Cohort..  Journal of the neurological sciences.  -. 2026
5. Premature aging in serious mental illness..  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.  2026
6. Biological Aging Acceleration in Major Depressive Disorder: A Multi-Omics Analysis..  Aging cell.  25:-. 2025
7. Oral and Periodontal Health Status, Peripheral Immune Dysregulation, and Cognitive Impairment in Alzheimer's Disease: A Clinical and Immunological Study..  International journal of molecular sciences.  26. 2025
8. Locus Coeruleus Microstructure and Connectivity as Novel Markers of Depression and Cognitive Dysfunction in Older Adults..  Biological psychiatry. Cognitive neuroscience and neuroimaging.  11:366-377. 2025
9. Predictors of fatigue in Individuals With Late-Life Depression..  The American journal of geriatric psychiatry. Open science, education, and practice.  7-11. 2025
10. Decreased Mitochondrial DNA Integrity and Elevated Inflammatory Markers in Late-Life Depression: A Longitudinal Study..  Biological psychiatry global open science.  5:-. 2025
11. Proteogenomic signature of Alzheimer's disease and related dementia risk in individuals with major depressive disorder..  Nature. Mental health.  3:879-888. 2025
12. The Senescence Associated Secretory Phenotype, a key marker of cellular senescence, is elevated in depression and moderated by sex..  International psychogeriatrics.  -. 2025
13. Preliminary Investigation of the Association Between Epigenetic Aging Acceleration and Amyloid Biomarkers in Bipolar Disorder..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  34:210-221. 2025
14. A proteomic signature of healthspan..  Proceedings of the National Academy of Sciences of the United States of America.  122:-. 2025
15. Protein Associations With Alcohol Consumption and Genetic Risk for Alcohol-Related Sociomedical Conditions..  Addiction biology.  30:-. 2025
16. Multiplexed CRISPR Assay for Amplification-Free Detection of miRNAs..  Biosensors.  15. 2025
17. Blood Angiogenesis Markers and Cognition in Older Adults at Risk for Dementia: Marqueurs sanguins de l'angiogenèse et cognition chez les personnes âgées à risque de démence..  Canadian journal of psychiatry. Revue canadienne de psychiatrie.  -. 2025
18. An Expert Consensus Statement on Biomarkers of Aging for Use in Intervention Studies..  The journals of gerontology. Series A, Biological sciences and medical sciences.  80. 2025
19. A proteomic signature of healthspan..  medRxiv : the preprint server for health sciences.  2025
20. Persistent elevation of plasma markers of cellular senescence after hip fracture: a pilot longitudinal study..  Frontiers in aging.  -. 2024
21. Liquid Biopsy in Neuropsychiatric Disorders: A Step Closer to Precision Medicine..  Molecular neurobiology.  62:3462-3479. 2024
22. Proteogenomic signature of risk of Alzheimer's disease and related dementia risk in individuals with a history of major depression disorder..  medRxiv : the preprint server for health sciences.  2024
23. Exosome-associated mitochondrial DNA in late-life depression: Implications for cognitive decline in older adults..  Journal of affective disorders.  217-224. 2024
24. Elevated senescence-associated secretory phenotype index in late-life bipolar disorder..  Journal of affective disorders.  163-168. 2024
25. Proteomic aging clock (PAC) predicts age-related outcomes in middle-aged and older adults..  Aging cell.  23:-. 2024
26. Proteomic aging clock (PAC) predicts age-related outcomes in middle-aged and older adults..  medRxiv : the preprint server for health sciences.  2024
27. Unraveling the association between major depressive disorder and senescent biomarkers in immune cells of older adults: a single-cell phenotypic analysis..  Frontiers in aging.  -. 2024
28. Computerized cognitive remediation of Long COVID in older adults..  International psychogeriatrics.  36:1267-1269. 2024
29. Sex differences in plasma proteomic markers in late-life depression..  Psychiatry research.  -. 2024
30. Immunotherapy in Alzheimer's Disease: From the Bench to the Bedside..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  32:584-585. 2024
31. CRISPR-Powered Aptasensor for Diagnostics of Alzheimer's Disease..  ACS sensors.  9:398-405. 2023
32. Relationship between baseline plasma p-tau181 and longitudinal changes in cognition and structural brain measures in a cohort of cognitively unimpaired older adults..  Alzheimer's & dementia (Amsterdam, Netherlands).  15:-. 2023
33. Geroscience-Centric Perspective for Geriatric Psychiatry: Integrating Aging Biology With Geriatric Mental Health Research..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  32:1-16. 2023
34. Does physical activity moderate the association between shorter leukocyte telomere length and incident coronary heart disease? Data from 54,180 UK Biobank participants..  GeroScience.  46:1331-1342. 2023
35. Mid-life leukocyte telomere length and dementia risk: An observational and mendelian randomization study of 435,046 UK Biobank participants..  Aging cell.  22:-. 2023
36. Plasma Biomarkers of Alzheimer's Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice..  Journal of Alzheimer's disease reports.  7:355-380. 2023
37. Major depression, physical health and molecular senescence markers abnormalities..  Nature. Mental health.  1:200-209. 2023
38. Neuroimaging features of depression-frailty phenotype in older adults: a pilot study..  International psychogeriatrics.  35:717-723. 2023
39. Sex differences in dementia risk and risk factors: Individual-participant data analysis using 21 cohorts across six continents from the COSMIC consortium..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  19:3365-3378. 2023
40. Effects of Mindfulness Training and Exercise on Cognitive Function in Older Adults: A Randomized Clinical Trial..  JAMA.  328:2218-2229. 2022
41. Abnormal expression of cortical cell cycle regulators underlying anxiety and depressive-like behavior in mice exposed to chronic stress..  Frontiers in cellular neuroscience.  -. 2022
42. Major depression and the biological hallmarks of aging..  Ageing research reviews.  -. 2022
43. Psychosocial Determinants of Biological Aging in Older Adults: What is Next?.  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  31:110-111. 2022
44. Associations between locus coeruleus integrity and diagnosis, age, and cognitive performance in older adults with and without late-life depression: An exploratory study..  NeuroImage. Clinical.  -. 2022
45. Plasma proteomic signature of major depressive episode in the elderly..  Journal of proteomics.  -. 2022
46. Late-Life Depression is Associated With Increased Levels of GDF-15, a Pro-Aging Mitokine..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  31:1-9. 2022
47. Higher IL-6 and IL-4 plasma levels in depressed elderly women are influenced by diabetes mellitus..  Trends in psychiatry and psychotherapy.  -. 2022
48. Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome..  JAMA network open.  5:-. 2022
49. Cognitive Frailty is Associated With Elevated Proinflammatory Markers and a Higher Risk of Mortality..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  30:825-833. 2022
50. Cognitive Frailty is Associated With Elevated Proinflammatory Markers and a Higher Risk of Mortality..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  30:825-833. 2022
51. Editorial: Cognitive Impairment and Inflammation in Old Age and the Role of Modifiable Risk Factors of Neurocognitive Disorders..  Frontiers in psychiatry.  -. 2021
52. Increased Levels of Circulating Cell-Free mtDNA in the Plasma of Subjects With Late-Life Depression and Frailty: A Preliminary Study..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  30:332-337. 2021
53. Increased Levels of Circulating Cell-Free mtDNA in the Plasma of Subjects With Late-Life Depression and Frailty: A Preliminary Study..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  30:332-337. 2021
54. Telomere shortening in late-life depression: A potential marker of depression severity..  Brain and behavior.  11:-. 2021
55. Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults..  Alzheimer's & dementia (New York, N. Y.).  7:-. 2021
56. The Links between Cardiovascular Diseases and Alzheimer's Disease..  Current neuropharmacology.  19:152-169. 2021
57. APOE ε4 and the Influence of Sex, Age, Vascular Risk Factors, and Ethnicity on Cognitive Decline..  The journals of gerontology. Series A, Biological sciences and medical sciences.  75:1863-1873. 2020
58. Oxidative DNA damage is increased in older adults with a major depressive episode: A preliminary study..  Journal of affective disorders.  106-110. 2020
59. Education and the moderating roles of age, sex, ethnicity and apolipoprotein epsilon 4 on the risk of cognitive impairment..  Archives of gerontology and geriatrics.  -. 2020
60. The Biopsychosocial Liability for Late-Life Depression..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  28:856-858. 2020
61. Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)..  BMC psychiatry.  20:-. 2020
62. Frailty and cognitive decline..  Translational research : the journal of laboratory and clinical medicine.  58-64. 2020
63. Association of Vitamin D Levels with Incident All-Cause Dementia in Longitudinal Observational Studies: A Systematic Review and Meta-analysis..  The journal of prevention of Alzheimer's disease.  7:14-20. 2020
64. Biomarkers intersection between depression, diabetes, and cognitive impairment..  International psychogeriatrics.  32:5-6. 2020
65. Mild and moderate cognitive impairment and mortality among Brazilian older adults in long-term follow-up: The Bambui Health Aging Study..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  42:583-590. 2020
66. Biomarkers intersection between depression, diabetes, and cognitive impairment..  International psychogeriatrics.  32:5-6. 2020
67. Mood Disorders and Dementia: Time for Action..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  28:542-544. 2019
68. Mood Disorders and Dementia: Time for Action..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  28:542-544. 2019
69. Major depression and enhanced molecular senescence abnormalities in young and middle-aged adults..  Translational psychiatry.  9:-. 2019
70. Diet and Alzheimer's dementia - Nutritional approach to modulate inflammation..  Pharmacology, biochemistry, and behavior.  -. 2019
71. Molecular Senescence Is Associated With White Matter Microstructural Damage in Late-Life Depression..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  27:1414-1418. 2019
72. Diabetes, depressive symptoms, and mortality risk in old age: The role of inflammation..  Depression and anxiety.  36:941-949. 2019
73. Brain-enriched MicroRNA-184 is downregulated in older adults with major depressive disorder: A translational study..  Journal of psychiatric research.  110-120. 2019
74. Epidermal growth factor and fibroblast growth factor-2 circulating levels in elderly with major depressive disorder..  Psychiatry research.  141-143. 2018
75. Depressive symptoms, emotional support and activities of daily living disability onset: 15-year follow-up of the Bambuí (Brazil) Cohort Study of Aging..  Cadernos de saude publica.  34:-. 2018
76. The Molecular Intersection Between Senescence and Major Depression in the Elderly..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  26:1097-1105. 2018
77. Stress, Inflammation, and Aging: An Association Beyond Chance..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  26:964-965. 2018
78. Stress, Inflammation, and Aging: An Association Beyond Chance..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  26:964-965. 2018
79. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review..  Molecular neurobiology.  56:1841-1851. 2018
80. Oxidative stress markers imbalance in late-life depression..  Journal of psychiatric research.  29-33. 2018
81. Potential Use of Stem Cells in Mood Disorders..  Advances in experimental medicine and biology.  87-96. 2018
82. The association between systemic lupus erythematosus and dementia A meta-analysis..  Dementia & neuropsychologia.  12:143-151. 2018
83. Depressive symptoms, emotional support and activities of daily living disability onset: 15-year follow-up of the Bambuí (Brazil) Cohort Study of Aging..  Cadernos de saude publica.  34:e00141917. 2018
84. Plasma IL-17A levels in patients with late-life depression..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  40:212-215. 2017
85. Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  14:280-292. 2017
86. The impact of substance use disorders on clinical outcomes in older-adult psychiatric inpatients..  International journal of geriatric psychiatry.  33:e323-e329. 2017
87. The association between insulin resistance, metabolic variables, and depressive symptoms in Mexican-American elderly: A population-based study..  International journal of geriatric psychiatry.  33:e294-e299. 2017
88. Is It All about Inflammation?.  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  25:1309-1310. 2017
89. Increased reward-oriented impulsivity in older bipolar patients: A preliminary study..  Journal of affective disorders.  585-592. 2017
90. History of Bipolar Disorder and the Risk of Dementia: A Systematic Review and Meta-Analysis..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  25:357-362. 2017
91. What can BDNF genotype tell us about our memory?.  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  39:87. 2017
92. The Vascular Impairment of Cognition Classification Consensus Study..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  13:624-633. 2016
93. Inflammatory Response in the CNS: Friend or Foe?.  Molecular neurobiology.  54:8071-8089. 2016
94. Vascular depression consensus report - a critical update..  BMC medicine.  14:-. 2016
95. The Relationship between Sleep Complaints, Depression, and Executive Functions on Older Adults..  Frontiers in psychology.  -. 2016
96. Enhanced Molecular Aging in Late-Life Depression: the Senescent-Associated Secretory Phenotype..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  25:64-72. 2016
97. Shared Biologic Pathways Between Alzheimer Disease and Major Depression: A Systematic Review of MicroRNA Expression Studies..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  24:903-12. 2016
98. Circulating biosignatures of late-life depression (LLD): Towards a comprehensive, data-driven approach to understanding LLD pathophysiology..  Journal of psychiatric research.  1-7. 2016
99. Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder..  Journal of psychiatric research.  112-8. 2016
100. Immunological biomarkers associated with brain structure and executive function in late-life depression: exploratory pilot study..  International journal of geriatric psychiatry.  32:692-699. 2016
101. Decreased Brain-Derived Neurotrophic Factor (BDNF) in Older Adults with Bipolar Disorder: Meaning and Utility?.  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  24:602-603. 2016
102. Components of the metabolic syndrome and depressive symptoms in community-dwelling older people: the Bambuí Cohort Aging Study..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  38:183-9. 2016
103. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial..  JAMA psychiatry.  73:329-36. 2016
104. Insomnia and risk of dementia in older adults: Systematic review and meta-analysis..  Journal of psychiatric research.  109-15. 2016
105. A Reanalysis of Cognitive-Functional Performance in Older Adults: Investigating the Interaction Between Normal Aging, Mild Cognitive Impairment, Mild Alzheimer's Disease Dementia, and Depression..  Frontiers in psychology.  -. 2016
106. Accuracy of three depression screening scales to diagnose major depressive episodes in older adults without neurocognitive disorders..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  38:154-6. 2016
107. The Relationship between Sleep Complaints, Depression, and Executive Functions on Older Adults. 2016
108. Vascular depression consensus report - a critical update. 2016
109. Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta-analysis..  International journal of geriatric psychiatry.  31:905-11. 2015
110. Trigeminal Nerve Stimulation (TNS) for Major Depressive Disorder in the Elderly: An Open Label Proof-of-Concept Trial..  Brain stimulation.  9:146-7. 2015
111. Antidepressant use and associated factors among the elderly: the Bambuí Project..  Ciencia & saude coletiva.  20:3797-804. 2015
112. Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia..  Alzheimer's & dementia (Amsterdam, Netherlands).  1:455-63. 2015
113. Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder..  Neuroscience letters.  65-8. 2015
114. Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis..  Journal of psychiatric research.  35-41. 2015
115. Specific cognitive functions and depressive symptoms as predictors of activities of daily living in older adults with heterogeneous cognitive backgrounds..  Frontiers in aging neuroscience.  -. 2015
116. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease..  Neuromolecular medicine.  17:326-32. 2015
117. Working Memory and Cognitive Flexibility Mediates Visuoconstructional Abilities in Older Adults with Heterogeneous Cognitive Ability..  Journal of the International Neuropsychological Society : JINS.  21:392-8. 2015
118. Bipolar disorder prevalence: a systematic review and meta-analysis of the literature..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  37:155-61. 2015
119. Predictors of incidence of clinically significant depressive symptoms in the elderly: 10-year follow-up study of the Bambui cohort study of aging..  International journal of geriatric psychiatry.  30:1171-6. 2015
120. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects..  Journal of Alzheimer's disease : JAD.  46:423-9. 2015
121. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects..  Journal of Alzheimer's disease : JAD.  46:423-9. 2015
122. Major depressive disorder in older adults: benefits and hazards of prolonged treatment..  Drugs & aging.  31:661-9. 2014
123. Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression..  The journals of gerontology. Series B, Psychological sciences and social sciences.  69:845-51. 2014
124. APOE ε4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: the Bambuí Cohort Study of Aging..  International journal of geriatric psychiatry.  30:573-9. 2014
125. Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression..  Molecular psychiatry.  20:594-601. 2014
126. Graph analysis of verbal fluency test discriminate between patients with Alzheimer's disease, mild cognitive impairment and normal elderly controls..  Frontiers in aging neuroscience.  -. 2014
127. ADHD inattentive symptoms mediate the relationship between intelligence and academic performance in children aged 6-14..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  36:313-21. 2014
128. Impaired generation of new subcategories and switching in a semantic verbal fluency test in older adults with mild cognitive impairment..  Frontiers in aging neuroscience.  -. 2014
129. Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension..  The Journal of clinical psychiatry.  75:e672-8. 2014
130. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes..  Psychopharmacology.  232:245-50. 2014
131. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders..  ACS chemical neuroscience.  5:443-50. 2014
132. Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study..  ACS chemical neuroscience.  5:484-9. 2014
133. The effect of gender, age, and symptom severity in late-life depression on the risk of all-cause mortality: the Bambuí Cohort Study of Aging..  Depression and anxiety.  31:787-95. 2013
134. Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study..  Journal of psychiatric research.  96-101. 2013
135. Clinical applicability and cutoff values for an unstructured neuropsychological assessment protocol for older adults with low formal education..  PloS one.  8:-. 2013
136. Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study..  Journal of neural transmission (Vienna, Austria : 1996).  121:193-200. 2013
137. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies..  The British journal of psychiatry : the journal of mental science.  202:329-35. 2013
138. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders..  Neuropsychiatric disease and treatment.  493-500. 2013
139. Cognitive impairment in euthymic older adults with bipolar disorder: a controlled study using cognitive screening tests..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  22:389-97. 2013
140. Reduced serum nerve growth factor in patients with late-life depression..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  21:493-6. 2013
141. Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  35:178-85. 2013
142. Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  35:284-94. 2013
143. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders..  Neuropsychiatric disease and treatment.  9:493-500. 2013
144. Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  35:178-85. 2013
145. Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer's disease..  PloS one.  7:-. 2012
146. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease..  Neuromolecular medicine.  15:115-21. 2012
147. Reduced serum levels of adiponectin in elderly patients with major depression..  Journal of psychiatric research.  46:1081-5. 2012
148. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression..  Journal of psychiatric research.  46:1053-8. 2012
149. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease..  Journal of neural transmission (Vienna, Austria : 1996).  119:815-9. 2012
150. Does lithium prevent Alzheimer's disease?.  Drugs & aging.  29:335-42. 2012
151. A radioenzymatic assay to identify three groups of phospholipase A(2) in platelets..  Prostaglandins, leukotrienes, and essential fatty acids.  86:149-53. 2012
152. Alzheimer's disease..  Sub-cellular biochemistry.  329-52. 2012
153. Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders..  Current opinion in psychiatry.  24:473-7. 2011
154. Circulating Glial-derived neurotrophic factor is reduced in late-life depression..  Journal of psychiatric research.  46:135-9. 2011
155. Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond..  Neuromolecular medicine.  13:217-22. 2011
156. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial..  The British journal of psychiatry : the journal of mental science.  198:351-6. 2011
157. Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains..  International journal of geriatric psychiatry.  26:403-8. 2011
158. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study..  Neuroscience letters.  494:54-6. 2011
159. Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?.  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.  12:216-22. 2011
160. Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders..  Current opinion in psychiatry.  24:473-7. 2011
161. Diagnosis and biomarkers of predementia in Alzheimer's disease..  BMC medicine.  -. 2010
162. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function..  Biomarkers in medicine.  4:871-87. 2010
163. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment..  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.  11:774-80. 2010
164. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease..  Journal of psychiatric research.  45:220-4. 2010
165. Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults..  Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.  25:335-43. 2010
166. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  32:216-22. 2010
167. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression..  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.  11:550-5. 2010
168. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression..  Journal of psychiatric research.  44:917-20. 2010
169. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement..  Journal of the International Neuropsychological Society : JINS.  16:297-305. 2010
170. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  18:172-6. 2010
171. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease..  Journal of Alzheimer's disease : JAD.  22:1305-11. 2010
172. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  32:216-22. 2010
173. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease..  Journal of Alzheimer's disease : JAD.  22:1305-11. 2010
174. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  18:172-6. 2010
175. Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies..  Neurobiology of aging.  32:1733-41. 2009
176. Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment..  Dementia and geriatric cognitive disorders.  28:507-12. 2009
177. Diagnostic transitions in mild cognitive impairment subtypes..  International psychogeriatrics.  21:1088-95. 2009
178. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education..  International psychogeriatrics.  21:1081-7. 2009
179. Neuropsychological profile of Brazilian older adults with heterogeneous educational backgrounds..  Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.  24:71-9. 2009
180. Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study..  Dementia and geriatric cognitive disorders.  27:224-31. 2009
181. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease..  European archives of psychiatry and clinical neuroscience.  259:248-56. 2009
182. Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly..  Clinics (Sao Paulo, Brazil).  64:967-73. 2009
183. Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?.  Dementia & neuropsychologia.  3:188-194. 2009
184. Diagnostic transitions in mild cognitive impairment subtypes..  International psychogeriatrics.  21:1088-95. 2009
185. Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?.  Dementia & neuropsychologia.  3:188-194. 2009
186. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education..  International psychogeriatrics.  21:1081-7. 2009
187. Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  30:346-9. 2008
188. Mild cognitive impairment: cognitive screening or neuropsychological assessment?.  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  30:316-21. 2008
189. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education..  International journal of geriatric psychiatry.  23:1127-33. 2008
190. Voxel-based morphometry in Alzheimer's disease..  Expert review of neurotherapeutics.  8:1691-702. 2008
191. [The use of antipsychotics in patients with dementia]..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  30:265-70. 2008
192. Cognitive training increases platelet PLA2 activity in healthy elderly subjects..  Prostaglandins, leukotrienes, and essential fatty acids.  78:265-9. 2008
193. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature..  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.  9:172-82. 2008
194. Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  30:346-9. 2008
195. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature..  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.  9:172-82. 2008
196. Mild cognitive impairment: cognitive screening or neuropsychological assessment?.  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  30:316-21. 2008
197. [The use of antipsychotics in patients with dementia]..  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999).  30:265-70. 2008
198. Mini-mental State Examination performance in mild cognitive impairment subtypes..  International psychogeriatrics.  19:647-56. 2007
199. Comparison between precipitin and ELISA tests in the bloodmeal detection of Aedes aegypti (Linnaeus) and Aedes fluviatilis (Lutz) mosquitoes experimentally fed on feline, canine and human hosts..  Memorias do Instituto Oswaldo Cruz.  96:693-5. 2001